Experimental rat bladder urothelial cell carcinoma models

World Journal of Urology

Volumn 27, Issue 3, 2009, Pages 313-317

  Arentsen, Harm C ^a   Hendricksen, Kees ^a   Oosterwijk, Egbert ^a   Witjes, J Alfred ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; Model; Orthotopic; Rat; Urothelial cell carcinoma

Indexed keywords

ANIMAL; ARTICLE; BLADDER TUMOR; DISEASE MODEL; RAT; TRANSITIONAL CELL CARCINOMA;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; DISEASE MODELS, ANIMAL; RATS; URINARY BLADDER NEOPLASMS;

EID: 67349200300     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0381-5     Document Type: Article

References (33)

1. Curado MP, Edwards B, Shin HR et al (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publications No.160. IARC, Lyon
2. Fleshner NE, Herr HW, Stewart AK, Murphy GP, Mettlin C, Menck HR (1996) The national cancer data base report on bladder carcinoma. Cancer 78:1505-1513. doi: 10.1002/ (SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3
3. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou J (2008) Guidelines on TaT1 (non-muscle invasive) bladder cancer. Eur Urol 54:303-314. doi: 10.1016/j.eururo.2008.04.051
4. Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466-477. doi: 10.1016/ j.eururo.2005.12.031
5. Xiao Z, McCallum TJ, Brown KM et al (1999) Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer 81:638-646. doi: 10.1038/sj.bjc.6690741
6. Oyasu R (1995) Epithelial tumours of the lower urinary tract in humans and rodents. Food Chem Toxicol 33:747-755. doi: 10.1016/ 0278-6915(95)00042-Z
7. Günther JH, Jurczok A, Wulf T et al (1999) Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res 59:2834-2837
8. Watanabe T, Shinohara N, Sazawa A et al (2000) An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies. Cancer Gene Ther 7:1575-1580. doi: 10.1038/sj.cgt.7700261
9. Chong L, Ruping Y, Jiancheng B et al (2006) Characterization of a novel transplantable orthotopic murine xenograft model of a human bladder transitional cell tumor (BIU-87). Cancer Biol Ther 5:394-398
10. Oshinsky GS, Chen Y, Jarrett T, Anderson AE, Weiss GH (1995) A model of bladder tumor xenografts in the nude rat. J Urol 154:1925-1929. doi: 10.1016/S0022-5347(01)66827-7
11. Van Moorselaar RJA, Ichikawa T, Schaafsma HE et al (1993) The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinoma. Urol Res 21:413-421. doi: 10.1007/BF00300078
12. Moltedo B, Faunes F, Haussmann D et al (2006) Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: Evidence for conserved antitumor properties among hemocyanins. J Urol 176:2690-2695. doi: 10.1016/j.juro.2006.07.136
13. Talmadge JE, Singh RK, Fidler IJ, Raz A (2007) Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170:793-804. doi: 10.2353/ajpath.2007.060929
14. Bibby MC (2004) Orthotopic models of cancer for preclinical drug evaluation: Advantages and disadvantages. Eur J Cancer 40:852-857. doi: 10.1016/j.ejca.2003.11.021
15. Wilmanns C, Fan D, O'Brian C et al (1993) Modulation of doxorubicin sensitivity and level of P-glycoprotein expression in human colon carcinoma cells by ectopic and orthotopic environments in nude mice. Int J Oncol 3:413-422
16. Grubbs CJ, Lubet RA, Koki AT et al (2000) Celecoxib inhibits N-Butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 60:5599-5602
17. Cohen SM (1998) Cell proliferation and carcinogenesis. Drug Metab Rev 30:339-357. doi: 10.3109/03602539808996317
18. Schalken JA, Van Moorselaar RJA, Bringuier PP, Debruyne FMJ (1992) Critical review of the models to study the biologic progression of bladder cancer. Semin Surg Oncol 8:274-278. doi: 10.1002/ssu.2980080505
19. Oliveira PA, Colaço A, De la Cruz LF, Lopes C (2006) Experimental bladder carcinogenesis-rodent models. Exp Oncol 28:2-11
20. Hendricksen K, Molkenboer-Kuenen J, Oosterwijk E, Hulsbergen-van de Kaa CA, Witjes JA (2008) Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy. BJU Int 101:889-893. doi: 10.1111/ j.1464-410X.2007.07407.x
21. Bisson J, Parache RM, Droulle P, Notter D, Vigneron C, Guillemin F (2002) A new method of implanting orthotopic rat bladder tumor for experimental therapies. Int J Cancer 102:280-285. doi: 10.1002/ijc.10595
22. Iinuma S, Bachor R, Flotte T, Hasan T (1995) Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol 153:802-806. doi: 10.1016/ S0022-5347(01)67726-7
23. Bindels EMJ, Vermey M, De Both NJ, Van der Kwast TH (2001) Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines. Virchows Arch 439:552-559. doi: 10.1007/s004280100419
24. Horiguchi Y, Kikuchi E, Ozu C et al (2008) Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments. Hum Cell 21:57-63. doi: 10.1111/j.1749-0774.2008.00055.x
25. Chin J, Kadhim S, Garcia B, Kim YS, Karlik S (1991) Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants. J Urol 145:1297-1301
26. Kikuchi E, Xu S, Ohori M et al (2003) Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging. J Urol 170:1375-1378. doi: 10.1097/ 01.ju.0000075504.13456.41
27. Satoh H, Morimoto Y, Arai T et al (2007) Intravesical ultrasonography for tumor staging in an orthotopically implanted rat model of bladder cancer. J Urol 177:1169-1173. doi: 10.1016/j.juro.2006.10.038
28. Hadaschik BA, Black PC, Sea JC et al (2007) A validated mouse model for orthotopic bladder cancer using transurethral tumor inoculation and bioluminescence imaging. BJU Int 100:1377-1384. doi: 10.1111/ j.1464-410X.2007.07165.x
29. Jurczok A, Fornara P, Söling A (2007) Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: A new approach to optimize a syngeneic orthotopic, murine bladder cancer model. BJU Int 101:120-124
30. Asanuma H, Arai T, Seguchi K et al (2003) Successful diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy. J Urol 169:718-720. doi: 10.1016/S0022-5347(05)64000-1
31. Van Moorselaar RJA, Hendriks BT, Borm G, Van der Meide PH, Debruyne FMJ, Schalken JA (1992) Inhibition of rat bladder tumor (RBT323) growth by tumor necrosis factor alpha and interferon-gamma in vivo. J Urol 148:458-462
32. Cornel EB, Van Moorselaar RJA, Van Stratum P, Debruyne FMJ, Schalken JA (1993) Antitumor effects of Bacillus Calmette-Guerin in a syngeneic rat bladder tumor model. J Urol 149:179-182
33. Williams PD, Lee JK, Theodorescu D (2008) Molecular credentialing of rodent bladder carcinogenesis models. Neoplasia 10:838-846